Continuous glucose monitoring system
Changsha, changsha, China
NCT Number: NCT07108179
Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Changsha, changsha, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous Glucose Monitoring (CGM) System
Time frame: Up to eight days
"Comparison between arterial blood gas analysis glucose values and CGM values at the same time"
Sinocare
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05464979
Critically Ill Patients
Wuhan, Hubei, China
View Trial DetailsNCT07583732
Critically Ill Patients
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT06486467
Critically Ill Patients, Tissue Hypoperfusion
Limoges, France
View Trial DetailsNCT07157748
Critically Ill Patients
Chongqing, Chongqing Municipality, China
View Trial Details